Scientific Posters & Publications

Title Date Type Size  
Metadoxine Selectively Reverses Tonic and Phasic GABAergic Transmission 01/16/2017 PDF 247.5 KB Add to Briefcase
Pooled Safety and Tolerability Data of Metadoxine Extended Release (MDX) from three 6-week placebo controlled clinical studies 01/16/2017 PDF 125.4 KB Add to Briefcase
MEASURE: A Phase 3 placebo-controlled study of Metadoxine Extended Release in Adults with Attention Deficit Hyperactivity Disorder   PDF 2.1 MB Add to Briefcase
A 6-week, Randomized, Multicenter, Double-blind, Parallel, Flexed- and Fixed-dose Study of MDX Compared with Placebo in Adolescents and Adults with Fragile X Syndrome 11/02/2015 PDF 152.6 KB Add to Briefcase
Metadoxine - a Novel Pro-cognitive Drug Modulating the Gamma-aminobutyric Acid (GABA) ergic System for Treatment of Cognitive Disorders 10/31/2015 PDF 126.5 KB Add to Briefcase
Metadoxine Affects Brain Activity in Neural Circuits Associated With Cognitive Dysfunctions: a Pharmacological MRI Study in Conscious Rats 01/16/2015 PDF 1.1 MB Add to Briefcase
Metadoxine – a Novel Synaptic Transmission Modulator With Low Abuse Potential in Development for Attention-Defi cit/Hyperactivity Disorder (ADHD) 10/23/2014 PDF 566.0 KB Add to Briefcase
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Metadoxine Extended Release 1400 mg Compared With Placebo Once Daily in 300 Adults With Attention-Defi cit/Hyperactivity Disorder 10/23/2014 PDF 570.8 KB Add to Briefcase
Metadoxine Extended Release (MDX) for the Treatment of Attention-Defi cit/Hyperactivity Disorder (ADHD) in Adults: A 6-Week, Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial 09/20/2014 PDF 773.5 KB Add to Briefcase
Attention Benefits After A Single Dose Of MDX in Adults With PI-ADHD 09/05/2014 PDF 579.7 KB Add to Briefcase
MDX: A Novel Drug Candidate for the Treatment of ADHD and Other Cognitive Disorders 06/17/2014 PDF 605.7 KB Add to Briefcase
Efficacy of Metadoxine Extended Release in Patients with Predominantly Inattentive Subtype Attention-Deficit/Hyperactivity Disorder 07/04/2013 PDF 1.0 MB Add to Briefcase
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy, Safety and Tolerability of Extended-Release Metadoxine in Adults With Attention-Deficit/Hyperactivity Disorder 03/07/2012 PDF 458.6 KB Add to Briefcase
Add to Briefcase = add file to Briefcase